Anticorps Recombinant de lapin anti-CD229/SLAMF3

CD229/SLAMF3 Recombinant Antibody for WB, IHC, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

souris

Applications

WB, IHC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

242312E8

N° de cat : 84817-4-PBS

Synonymes

Lymphocyte antigen 9, Ly-9, Ly9, Cell surface molecule Ly-9, CD229



Informations sur le produit

84817-4-PBS cible CD229/SLAMF3 dans les applications de WB, IHC, Indirect ELISA et montre une réactivité avec des échantillons souris

Réactivité souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Protéine recombinante
Nom complet lymphocyte antigen 9
Masse moléculaire calculée73 kDa
Poids moléculaire observé80-90 kDa, 110 kDa
Numéro d’acquisition GenBankNM_001277968.1
Symbole du gène Ly9
Identification du gène (NCBI) 17085
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Signaling lymphocytic activation molecule 3 (SLAMF3), also known as CD229 or Ly9, is a type I transmembrane glycoprotein that belongs to the SLAM family receptors (PMID: 10970093; 15905546). It is composed of an extracellular region, which consists of four Ig-like domains, a transmembrane region, and a cytoplasmic tail, which includes two immunoreceptor tyrosine-based signaling motifs (ITSMs) and other tyrosine residues that act as binding sites for the SH2 structural domains (PMID: 8537117; 11369645; 38626547). SLAMF3 is mainly expressed in immune cells, such as T, B, and natural killer cells, and it is involved in the fundamental activation and suppression of these immune cells, as well as the regulation of complex immune networks (PMID: 38626547).

{{ptg:RelatedPrimaryAntibodies}}